Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:
Schedule
Product: Isentress
Active Ingredient: Raltegravir potassium 434.3mg equivalent to Raltegravir 400mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme Corp, Elkton, United States of America
MSD Technology Singapore Pte Limited, Avenue 6, Singapore
Note: This renewed consent is valid for two years from 4 September 2010.
Dated this 24th day of June 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).